![]()
![]()
![]()
Fig. 1. Generation of Mi3-EDIII nanoparticle vaccine.
![]()
Fig. 2. Antigenic profiling of Mi3-EDIII.
![]()
Fig. 3. Immunogenicity of Mi3-EDIII in C57BL/6 mice.
![]()
Fig. 4. Protective efficacy of Mi3-EDIII in challenged neonatal mice.
![]()
Fig. 5. Immunogenicity and protective efficacy of Mi3-EDIII in Ifnar1 C57BL/6 mice.
![]()
Fig. 6. ADE effects of immune sera on ZIKV or DENV infection in K562 cells.
![]()
Supplementary Fig. S1. Neutralizing activities of mAbs 7B3, 8D10 and 8-4.
![]()
Supplementary Fig. S2. SDS-PAGE analysis of recombinant E404.
![]()
Supplementary Fig. S3. Frequency of GC B cells among total B cells in ILNs at week 8.
歡迎來到醫食參考新媒體矩陣
2023年疫苗接種攻略
陽過了,該怎么打疫苗?最全接種指導手冊來了
撰寫| 中國病毒學英文版
校稿| Gddra編審| Hide / Blue sea
編輯 設計| Alice
特別聲明:以上內容(如有圖片或視頻亦包括在內)為自媒體平臺“網易號”用戶上傳并發布,本平臺僅提供信息存儲服務。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.